Current perspective on pediatric pharmacogenomics

Expert Opin Drug Metab Toxicol. 2016;12(4):363-5. doi: 10.1517/17425255.2016.1145656. Epub 2016 Feb 15.

Authors

Rachid Abaji^{1

2}, Maja Krajinovic^{1

3}

Affiliations

¹ a Research Center, CHU Sainte-Justine , University of Montreal , Montreal , Quebec , Canada.
² b Department of Pharmacology , University of Montreal , Montreal , Quebec , Canada.
³ c Departments of Pediatrics and Pharmacology , University of Montreal , Montreal , Quebec , Canada.

PMID: 26799591
DOI: 10.1517/17425255.2016.1145656

No abstract available

Publication types

Editorial

MeSH terms

Child
Cytochrome P-450 CYP2D6 / genetics
Cytochrome P-450 CYP2D6 / metabolism
Dose-Response Relationship, Drug
Evidence-Based Medicine
Humans
Pediatrics*
Pharmacogenetics*
Pharmacogenomic Variants
Precision Medicine

Substances

Cytochrome P-450 CYP2D6